1. Home
  2. CCO vs IVA Comparison

CCO vs IVA Comparison

Compare CCO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCO
  • IVA
  • Stock Information
  • Founded
  • CCO 1995
  • IVA 2011
  • Country
  • CCO United States
  • IVA France
  • Employees
  • CCO N/A
  • IVA N/A
  • Industry
  • CCO Advertising
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCO Consumer Discretionary
  • IVA Health Care
  • Exchange
  • CCO Nasdaq
  • IVA Nasdaq
  • Market Cap
  • CCO 924.4M
  • IVA 769.0M
  • IPO Year
  • CCO 2005
  • IVA 2020
  • Fundamental
  • Price
  • CCO $1.82
  • IVA $4.15
  • Analyst Decision
  • CCO Hold
  • IVA Strong Buy
  • Analyst Count
  • CCO 5
  • IVA 7
  • Target Price
  • CCO $2.13
  • IVA $16.57
  • AVG Volume (30 Days)
  • CCO 4.3M
  • IVA 354.0K
  • Earning Date
  • CCO 11-06-2025
  • IVA 09-29-2025
  • Dividend Yield
  • CCO N/A
  • IVA N/A
  • EPS Growth
  • CCO N/A
  • IVA N/A
  • EPS
  • CCO 0.04
  • IVA N/A
  • Revenue
  • CCO $1,538,895,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • CCO $6.16
  • IVA N/A
  • Revenue Next Year
  • CCO $4.01
  • IVA N/A
  • P/E Ratio
  • CCO $44.61
  • IVA N/A
  • Revenue Growth
  • CCO 31.61
  • IVA N/A
  • 52 Week Low
  • CCO $0.81
  • IVA $2.11
  • 52 Week High
  • CCO $2.03
  • IVA $7.98
  • Technical
  • Relative Strength Index (RSI)
  • CCO 68.20
  • IVA 38.70
  • Support Level
  • CCO $1.85
  • IVA $3.79
  • Resistance Level
  • CCO $2.03
  • IVA $7.98
  • Average True Range (ATR)
  • CCO 0.12
  • IVA 0.75
  • MACD
  • CCO 0.03
  • IVA -0.12
  • Stochastic Oscillator
  • CCO 86.64
  • IVA 5.84

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: